Chiappori, A. A., Williams, C. C., Gray, J. E., Tanvetyanon, T., Haura, E. B., Creelan, B. C., . . . Antonia, S. J. (2018). Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer. Cancer Immunol Immunother.
Citação norma ChicagoChiappori, Alberto A., et al. "Randomized-controlled Phase II Trial of Salvage Chemotherapy After Immunization With a TP53-transfected Dendritic Cell-based Vaccine (Ad.p53-DC) in Patients With Recurrent Small Cell Lung Cancer." Cancer Immunol Immunother 2018.
Citação norma MLAChiappori, Alberto A., et al. "Randomized-controlled Phase II Trial of Salvage Chemotherapy After Immunization With a TP53-transfected Dendritic Cell-based Vaccine (Ad.p53-DC) in Patients With Recurrent Small Cell Lung Cancer." Cancer Immunol Immunother 2018.